LOW-VOLUME · SEX-BALANCED
pimecrolimus Side Effects
pimecrolimus (also sold as Elidel) is a LOW-VOLUME FAERS extract #472 of 524 by FAERS report count. Still opens on SEX-BALANCED: 64% of sex-coded reports are female (891 F / 491 M).
Data updated 2026-05-15
- 1,541
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
pimecrolimus reporting skew - 64% of sex-coded reports are female (891 F / 491 M). Volume band LOW-VOLUME #472 of 524 by FAERS report count; caseload SIGNAL.
Thinner FAERS extract for pimecrolimus (Elidel) (1,541 reports #472 of 524 by FAERS report count). 64% of sex-coded reports are female (891 F / 491 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
DERMATITIS ATOPIC leads 178 of 1,541 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (294 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 21 reports (1.4% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| DEATH | 8 |
| ASCITES | 3 |
| AZOTAEMIA | 3 |
| CANDIDA SEPSIS | 3 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 3 |
| PNEUMONIA ASPIRATION | 3 |
| PRURITUS | 3 |
| ACUTE PULMONARY OEDEMA | 2 |
| BACTERAEMIA | 2 |
| BLOOD BILIRUBIN INCREASED | 2 |
| CHOLESTASIS | 2 |
| DISEASE PROGRESSION | 2 |
| FALL | 2 |
| FLUID OVERLOAD | 2 |
| LACTIC ACIDOSIS | 2 |
| MALIGNANT NEOPLASM PROGRESSION | 2 |
| PORTAL HYPERTENSION | 2 |
| URINARY TRACT INFECTION | 2 |
| ABDOMINAL PAIN UPPER | 1 |
Reactions in Hospitalization Reports
Hospitalization mid-share (183, 11.9%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| FATIGUE | 12 |
| CROHN^S DISEASE | 11 |
| PNEUMONIA | 10 |
| ARTHRALGIA | 9 |
| DIARRHOEA | 9 |
| HOSPITALISATION | 9 |
| PAIN | 9 |
| COVID-19 | 8 |
| ERYTHEMA | 8 |
| HYPOTENSION | 8 |
| URINARY TRACT INFECTION | 8 |
| BACK PAIN | 7 |
| DYSPNOEA | 7 |
| NAUSEA | 7 |
| PYREXIA | 7 |
| RASH | 7 |
| SKIN INFECTION | 7 |
| COUGH | 6 |
How to read pimecrolimus FAERS figures (SIGNAL · DEATH-MARKED · HOSP-MID)
FAERS holds 1,541 voluntary reports linked to pimecrolimus (Elidel), 2004-2025. Death is listed on 21 (1.4%). Hospitalization appears on 183 (11.9%). Top co-reported indication: Dermatitis Atopic.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with pimecrolimus
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 1,538 FAERS cases (Δ 3 lighter vs pimecrolimus); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 1,547 FAERS cases (Δ 6 heavier vs pimecrolimus); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 1,551 FAERS cases (Δ 10 heavier vs pimecrolimus); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 1,527 FAERS cases (Δ 14 lighter vs pimecrolimus); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 60.7 pp vs pimecrolimus's DEATH-MARKED): CASELOAD · HOSP-MID.
pimecrolimus stamps SIGNAL · SEX-BALANCED; class peers and methodology beat restating the same FAERS caveats on every effects URL.